Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aimei Health Technology Co., Ltd ( (AFJK) ) has provided an announcement.
Aimei Health Technology Co., Ltd. extended the deadline for completing its initial business combination from February 6, 2026, to March 6, 2026, by depositing $34,330.96 into its trust account for public shareholders, marking the fifteenth such one-month extension under its governing documents. The extension was funded through an unsecured promissory note of the same amount issued on February 12, 2026, to its sponsor Aimei Health Ltd. and United Hydrogen Group Inc., with repayment tied to the closing of their proposed business combination and an option for the payees to convert the note into private units, underscoring continued commitment to completing the deal and preserving the SPAC structure for investors.
More about Aimei Health Technology Co., Ltd
Aimei Health Technology Co., Ltd. is a special purpose acquisition company (SPAC) that has raised capital from public shareholders and holds the proceeds in a trust account while seeking to consummate an initial business combination. The company is currently focused on completing a proposed business combination with United Hydrogen Group Inc., reflecting a transaction-driven strategy rather than ongoing operating activities.
Average Trading Volume: 218,254
Technical Sentiment Signal: Strong Buy
Current Market Cap: $295.4M
Find detailed analytics on AFJK stock on TipRanks’ Stock Analysis page.